IntroductionDespite recent advances in immunotherapy for hepatocellular carcinoma (HCC). the overall modest response rate underscores the need for a better understanding of the tumor microenvironment (TME) of HCC. We have previously shown that CD38 is widely expressed on tumor-infiltrating leukocytes (TILs). predominantly on CD3+ T cells and monocytes. https://halohealthcarers.shop/product-category/reachers/